DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ATP
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ATP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LETETRESGENE AUTOLEUCEL
2
Gene
Investigational
Unknown
Unknown
Neoplasms
Unknown
LETETRESGENE AUTOLEUCEL
×
Maximum Phase:
2
First Approval:
None
UNII:
B5ME4ZU4BS
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PALMIDROL
2
Small molecule
Investigational
Unknown
Unknown
Tourette Syndrome
Unknown
PALMIDROL
×
Maximum Phase:
2
First Approval:
None
UNII:
6R8T1UDM3V
Molecule Type:
Small molecule
Molecular Formula:
C18H37NO2
Molecular Weight:
299.5
AlogP:
4.58
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
16.0
Source:
GOLOTIMOD
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic; Stomatitis
Unknown
GOLOTIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
637C487Y09
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O5
Molecular Weight:
333.34
AlogP:
0.47
PSA:
145.51
HBD:
5.0
HBA:
#RotB:
8.0
Source:
BI 44370 TA
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BI 44370 TA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
(+)-EPICATECHIN
2
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne; Prediabetic State; Friedreich Ataxia; Hypertension
Unknown
(+)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
LD6B6TT8Q5
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
CHOLESTEROL
2
Small molecule
Investigational
Unknown
Unknown
Asperger Syndrome; Autistic Disorder; Head and Neck Neoplasms; Porokeratosis; Smith-Lemli-Opitz Syndrome
Unknown
CHOLESTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
97C5T2UQ7J
Molecule Type:
Small molecule
Molecular Formula:
C27H46O
Molecular Weight:
386.66
AlogP:
7.39
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CLA
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CLA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARRAGEENAN
2
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome; Conjunctivitis, Viral; Papillomavirus Infections
Unknown
CARRAGEENAN
×
Maximum Phase:
2
First Approval:
None
UNII:
5C69YCD2YJ
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIROMELATINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Sleep Initiation and Maintenance Disorders
Melatonin receptor agonist
PIROMELATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
S3UN2146K9
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O4
Molecular Weight:
312.33
AlogP:
2.1
PSA:
84.33
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SABARUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Testicular Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
SABARUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XS499WOZ93
Molecule Type:
Small molecule
Molecular Formula:
C32H37NO13
Molecular Weight:
643.64
AlogP:
-0.13
PSA:
235.53
HBD:
7.0
HBA:
#RotB:
6.0
Source:
L 756423
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
L 756423
×
Maximum Phase:
2
First Approval:
None
UNII:
862SGU1BRL
Molecule Type:
Small molecule
Molecular Formula:
C39H48N4O5
Molecular Weight:
652.84
AlogP:
4.22
PSA:
118.28
HBD:
4.0
HBA:
#RotB:
11.0
Source:
DELEOBUVIR SODIUM
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
DELEOBUVIR SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
6X4T3L6431
Molecule Type:
Small molecule
Molecular Formula:
C34H32BrN6NaO3
Molecular Weight:
675.56
AlogP:
6.85
PSA:
114.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TOREFORANT
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Histamine H4 receptor antagonist
TOREFORANT
×
Maximum Phase:
2
First Approval:
None
UNII:
U6LA7G393X
Molecule Type:
Small molecule
Molecular Formula:
C23H32N6
Molecular Weight:
392.55
AlogP:
4.48
PSA:
69.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PILARALISIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Lymphoma; Neoplasms; Endometrial Neoplasms
PI3-kinase class I inhibitor
PILARALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
60ES45KTMK
Molecule Type:
Small molecule
Molecular Formula:
C25H25ClN6O4S
Molecular Weight:
541.03
AlogP:
4.51
PSA:
148.33
HBD:
4.0
HBA:
#RotB:
8.0
Source:
IMO-8400
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IMO-8400
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENETHYL ISOTHIOCYANATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PHENETHYL ISOTHIOCYANATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROLIPRAM
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Huntington Disease; Nervous System Diseases; Multiple Sclerosis
Unknown
ROLIPRAM
×
Maximum Phase:
2
First Approval:
None
UNII:
K676NL63N7
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO3
Molecular Weight:
275.35
AlogP:
2.62
PSA:
47.56
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SAR-113945
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
SAR-113945
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VIB4920
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
VIB4920
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LT-NS001
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LT-NS001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOFIMILAST
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
TOFIMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
5D7022962A
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5S
Molecular Weight:
339.47
AlogP:
4.1
PSA:
48.53
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LOMETREXOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Lung Neoplasms
Unknown
LOMETREXOL
×
Maximum Phase:
2
First Approval:
None
UNII:
6P3AVY8A7Q
Molecule Type:
Small molecule
Molecular Formula:
C21H25N5O6
Molecular Weight:
443.46
AlogP:
0.62
PSA:
187.5
HBD:
6.0
HBA:
#RotB:
9.0
Source:
MICROCRYSTALLINE CELLULOSE
2
Unknown
Investigational
Unknown
Unknown
Sleep Apnea, Obstructive; Anemia, Sickle Cell; Glioblastoma; Lewy Body Disease; Diabetes Mellitus, Type 2; Hypertension; Osteoarthritis, Knee; Infections
Unknown
MICROCRYSTALLINE CELLULOSE
×
Maximum Phase:
2
First Approval:
None
UNII:
OP1R32D61U
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CILUPREVIR
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatitis C virus serine protease, NS3/NS4A inhibitor
CILUPREVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
75C8DU40T0
Molecule Type:
Small molecule
Molecular Formula:
C40H50N6O8S
Molecular Weight:
774.94
AlogP:
6.05
PSA:
181.31
HBD:
4.0
HBA:
#RotB:
9.0
Source:
PD-360324
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Lupus Erythematosus, Cutaneous; Fallopian Tube Neoplasms; Neoplasms; Ovarian Neoplasms; Sarcoidosis, Pulmonary
Macrophage colony-stimulating factor 1 inhibitor
PD-360324
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KP-1461
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
DNA disrupting agent
KP-1461
×
Maximum Phase:
2
First Approval:
None
UNII:
3PEN569TJP
Molecule Type:
Small molecule
Molecular Formula:
C16H28N4O6
Molecular Weight:
372.42
AlogP:
0.49
PSA:
132.72
HBD:
4.0
HBA:
#RotB:
8.0
Source:
LFF-571
2
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections
Unknown
LFF-571
×
Maximum Phase:
2
First Approval:
None
UNII:
W7AUL2R95Z
Molecule Type:
Small molecule
Molecular Formula:
C60H63N13O13S6
Molecular Weight:
1366.64
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ATACICEPT
2
Protein
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Glomerulonephritis, IGA; Lupus Erythematosus, Systemic; Lupus Nephritis; Multiple Sclerosis; Optic Neuritis
Tumor necrosis factor ligand superfamily member 13B inhibitor
ATACICEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
K3D9A0ICQ3
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLUCOSAMINE SULFATE POTASSIUM CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GLUCOSAMINE SULFATE POTASSIUM CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
15VQ11I66N
Molecule Type:
Small molecule
Molecular Formula:
C12H28Cl2K2N2O14S
Molecular Weight:
605.53
AlogP:
-3.25
PSA:
116.17
HBD:
5.0
HBA:
#RotB:
1.0
Source:
PIXANTRONE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms
DNA cross-linking agent
PIXANTRONE
×
Maximum Phase:
2
First Approval:
None
UNII:
F5SXN2KNMR
Molecule Type:
Small molecule
Molecular Formula:
C17H19N5O2
Molecular Weight:
325.37
AlogP:
0.6
PSA:
123.13
HBD:
4.0
HBA:
#RotB:
6.0
Source:
ADU-S100
2
Unknown
Investigational
Unknown
Unknown
Lymphoma; Head and Neck Neoplasms
Stimulator of interferon genes protein agonist
ADU-S100
×
Maximum Phase:
2
First Approval:
None
UNII:
FMW9ZVF53N
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLATELETS
2
Unknown
Investigational
Unknown
Unknown
Osteoarthritis; Brain Injuries; Dupuytren Contracture; Stroke; Thrombocytopenia; Hemorrhage; Wounds and Injuries
Unknown
PLATELETS
×
Maximum Phase:
2
First Approval:
None
UNII:
V82T6JEZ99
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIVIFENE
2
Small molecule
Investigational
Unknown
Unknown
Lymphoproliferative Disorders; Sarcoma, Kaposi; Cervical Intraepithelial Neoplasia
Unknown
SIVIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
XAV05295I5
Molecule Type:
Small molecule
Molecular Formula:
C19H14N4O6
Molecular Weight:
394.34
AlogP:
3.78
PSA:
151.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FIRSOCOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Non-alcoholic Fatty Liver Disease
Acetyl-CoA carboxylase negative allosteric modulator
FIRSOCOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
XE10NJQ95M
Molecule Type:
Small molecule
Molecular Formula:
C28H31N3O8S
Molecular Weight:
569.64
AlogP:
3.95
PSA:
135.02
HBD:
1.0
HBA:
#RotB:
9.0
Source:
1
2
…
177
178
179
180
181
182
183
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA